Home
FAQ
Contact us
English
Français

English

of Université de Montréal at Hôpital Maisonneuve-Rosemont

Home
About us
- Mission
- Team
Multiple myeloma
- Diagnosis
- Myeloma Canada
Health professionals
- Clinical research protocols
Research program
Partners
Make a donation
Contact us

Carole Bélanger

Carole Bélanger

Secretary of the clinical research unit on multiple myeloma since 2012.

« See the other members of the team

Search

Search for:

News

Le pomalidomide figure maintenant sur la liste des médicaments d’exception 16 November 2016
Santé Canada approuve le Carfilzomib 16 November 2016
Santé Canada approuve le Daratumumab 16 November 2016
L’INESSS recommande au ministre de la santé de ne pas inscrire le Pomalidomide sur la liste de médicament pour le traitement du myélome multiple 16 November 2016

Archives

November 2016

Multiple myeloma is a blood cancer caused by the proliferation and accumulation of a certain type of white blood cell which produces malignant cells called myeloma cells.

Read more

Quick links

Multiple myeloma
Diagnosis
Team
Guidelines on multiple myeloma

Interesting links

Myeloma Canada
Université de Montréal
Fondation HMR
Hôpital Maisonneuve-Rosemont
Celgene inc.

Contact information

5415 de l'Assomption blvd.
Montreal, Québec H1T 2M4

Tel: 514 252-3400, ext. 4471
(For clininal research)

© All Rights Reserved 2019. Myeloma Canada Chair